University Park Hematology Oncology

U.P. Oncolytics is pioneering the future of cancer treatment through the innovative use of oncolytic viruses, which exploit the natural oncolytic and immunomodulatory properties of viruses. Their mission is to revolutionize cancer therapeutics, particularly for difficult-to-treat cancers like glioblastoma, by developing safe and effective viral therapies that target cancer cells while sparing normal cells.

Recognizing that cancer is a deeply personal disease with unique cellular changes, U.P. Oncolytics focuses on creating specific treatments tailored to the varied challenges presented by glioblastomas. By advancing oncolytic viral therapies, they aim to provide new hope for patients and families facing these aggressive forms of cancer.

Generated from the website